Academic Journal
View in EDS

hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients

Bibliographic Details
Title: hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients
Authors: Fengjiao Han, Haiyang Guo, Hao Zhang, Yang Zheng
Source: Frontiers in Endocrinology, Vol 16 (2025)
Publisher Information: Frontiers Media S.A., 2025.
Publication Year: 2025
Collection: LCC:Diseases of the endocrine glands. Clinical endocrinology
Subject Terms: cardiovascular-kidney-metabolic syndrome, high-sensitivity C-reactive protein, high-density lipoprotein cholesterol, mortality, CHARLS, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
More Details: BackgroundThe precise function of the hs-CRP/HDL-C ratio in forecasting the long-term mortality risk of patients with stages 1-4 of Cardiovascular-Kidney-Metabolic (CKM) syndrome remains inadequately delineated. This study investigates the potential correlation between the hs-CRP/HDL-C ratio and long-term mortality risk in individuals with CKM syndrome stages 1-4.MethodsThis prospective cohort study utilises data from the China Health and Retirement Longitudinal Study (CHARLS) project, encompassing 6,719 people who satisfied stringent criteria. We developed three Cox proportional hazards regression models to investigate the potential relationship between the hs-CRP/HDL-C ratio and long-term mortality risk in patients with CKM stages 1-4. We employed Restricted Cubic Spline (RCS) curves for analysis to identify any potential nonlinear correlations. Furthermore, we performed Receiver Operating Characteristic (ROC) curve analysis to evaluate predictive performance and identify the appropriate cut-off value. To enhance the research findings, we conducted a stratified analysis to investigate the influence of various sociodemographic factors on this association.ResultsIn individuals with CKM syndrome stages 1-4, the 10-year incidence of all-cause mortality was 14.1%. Upon controlling for additional potential confounding variables, the outcomes of the Cox proportional hazards regression model distinctly demonstrated a statistically significant linear positive association between the hs-CRP/HDL-C ratio and the long-term mortality risk in patients. For each quartile increase in the hs-CRP/HDL-C ratio, the probability of poor outcomes (i.e., mortality) escalated by 15% (Hazard Ratio, HR = 1.15, 95% Confidence Interval, CI: 1.09–1.22, p-value < 0.001). Moreover, the integration of the hs-CRP/HDL-C ratio into the baseline risk prediction model, with all pertinent factors thoroughly adjusted, markedly enhanced the model’s predictive capacity, facilitating a more precise assessment of long-term mortality risk in patients with CKM syndrome stages 1-4.ConclusionThis study identified a positive linear association between the hs-CRP/HDL-C ratio and long-term mortality risk in patients with stages 1 to 4 of CKM syndrome. This remarkable discovery not only offers a crucial reference for enhancing early individualised treatment options but also greatly aids in the early identification of patients with poor prognoses, hence presenting a novel perspective for improving clinical management pathways for these individuals.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-2392
Relation: https://www.frontiersin.org/articles/10.3389/fendo.2025.1552219/full; https://doaj.org/toc/1664-2392
DOI: 10.3389/fendo.2025.1552219
Access URL: https://doaj.org/article/695e4c32dd4c4688beffbe5693870278
Accession Number: edsdoj.695e4c32dd4c4688beffbe5693870278
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16642392&ISBN=&volume=16&issue=&date=20250401&spage=&pages=&title=Frontiers in Endocrinology&atitle=hs-CRP%2FHDL-C%20can%20predict%20the%20risk%20of%20all%20cause%20mortality%20in%20cardiovascular-kidney-metabolic%20syndrome%20stage%201-4%20patients&aulast=Fengjiao%20Han&id=DOI:10.3389/fendo.2025.1552219
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/695e4c32dd4c4688beffbe5693870278
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.695e4c32dd4c4688beffbe5693870278
RelevancyScore: 1057
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1056.58959960938
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients
– Name: Author
  Label: Authors
  Group: Au
  Data: &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Fengjiao+Han%22&quot;&gt;Fengjiao Han&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Haiyang+Guo%22&quot;&gt;Haiyang Guo&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Hao+Zhang%22&quot;&gt;Hao Zhang&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Yang+Zheng%22&quot;&gt;Yang Zheng&lt;/searchLink&gt;
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Frontiers in Endocrinology, Vol 16 (2025)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Frontiers Media S.A., 2025.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2025
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Diseases of the endocrine glands. Clinical endocrinology
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22cardiovascular-kidney-metabolic+syndrome%22&quot;&gt;cardiovascular-kidney-metabolic syndrome&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22high-sensitivity+C-reactive+protein%22&quot;&gt;high-sensitivity C-reactive protein&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22high-density+lipoprotein+cholesterol%22&quot;&gt;high-density lipoprotein cholesterol&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22mortality%22&quot;&gt;mortality&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22CHARLS%22&quot;&gt;CHARLS&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Diseases+of+the+endocrine+glands%2E+Clinical+endocrinology%22&quot;&gt;Diseases of the endocrine glands. Clinical endocrinology&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22RC648-665%22&quot;&gt;RC648-665&lt;/searchLink&gt;
– Name: Abstract
  Label: Description
  Group: Ab
  Data: BackgroundThe precise function of the hs-CRP/HDL-C ratio in forecasting the long-term mortality risk of patients with stages 1-4 of Cardiovascular-Kidney-Metabolic (CKM) syndrome remains inadequately delineated. This study investigates the potential correlation between the hs-CRP/HDL-C ratio and long-term mortality risk in individuals with CKM syndrome stages 1-4.MethodsThis prospective cohort study utilises data from the China Health and Retirement Longitudinal Study (CHARLS) project, encompassing 6,719 people who satisfied stringent criteria. We developed three Cox proportional hazards regression models to investigate the potential relationship between the hs-CRP/HDL-C ratio and long-term mortality risk in patients with CKM stages 1-4. We employed Restricted Cubic Spline (RCS) curves for analysis to identify any potential nonlinear correlations. Furthermore, we performed Receiver Operating Characteristic (ROC) curve analysis to evaluate predictive performance and identify the appropriate cut-off value. To enhance the research findings, we conducted a stratified analysis to investigate the influence of various sociodemographic factors on this association.ResultsIn individuals with CKM syndrome stages 1-4, the 10-year incidence of all-cause mortality was 14.1%. Upon controlling for additional potential confounding variables, the outcomes of the Cox proportional hazards regression model distinctly demonstrated a statistically significant linear positive association between the hs-CRP/HDL-C ratio and the long-term mortality risk in patients. For each quartile increase in the hs-CRP/HDL-C ratio, the probability of poor outcomes (i.e., mortality) escalated by 15% (Hazard Ratio, HR = 1.15, 95% Confidence Interval, CI: 1.09–1.22, p-value &lt; 0.001). Moreover, the integration of the hs-CRP/HDL-C ratio into the baseline risk prediction model, with all pertinent factors thoroughly adjusted, markedly enhanced the model’s predictive capacity, facilitating a more precise assessment of long-term mortality risk in patients with CKM syndrome stages 1-4.ConclusionThis study identified a positive linear association between the hs-CRP/HDL-C ratio and long-term mortality risk in patients with stages 1 to 4 of CKM syndrome. This remarkable discovery not only offers a crucial reference for enhancing early individualised treatment options but also greatly aids in the early identification of patients with poor prognoses, hence presenting a novel perspective for improving clinical management pathways for these individuals.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1664-2392
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.frontiersin.org/articles/10.3389/fendo.2025.1552219/full; https://doaj.org/toc/1664-2392
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3389/fendo.2025.1552219
– Name: URL
  Label: Access URL
  Group: URL
  Data: &lt;link linkTarget=&quot;URL&quot; linkTerm=&quot;https://doaj.org/article/695e4c32dd4c4688beffbe5693870278&quot; linkWindow=&quot;_blank&quot;&gt;https://doaj.org/article/695e4c32dd4c4688beffbe5693870278&lt;/link&gt;
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.695e4c32dd4c4688beffbe5693870278
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.695e4c32dd4c4688beffbe5693870278
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fendo.2025.1552219
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: cardiovascular-kidney-metabolic syndrome
        Type: general
      – SubjectFull: high-sensitivity C-reactive protein
        Type: general
      – SubjectFull: high-density lipoprotein cholesterol
        Type: general
      – SubjectFull: mortality
        Type: general
      – SubjectFull: CHARLS
        Type: general
      – SubjectFull: Diseases of the endocrine glands. Clinical endocrinology
        Type: general
      – SubjectFull: RC648-665
        Type: general
    Titles:
      – TitleFull: hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fengjiao Han
      – PersonEntity:
          Name:
            NameFull: Haiyang Guo
      – PersonEntity:
          Name:
            NameFull: Hao Zhang
      – PersonEntity:
          Name:
            NameFull: Yang Zheng
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 16642392
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in Endocrinology
              Type: main
ResultId 1